Next Generation kits and methods for DNA extraction and analysis towards more convenience, quality and speed Improving convenience, speed and quality.

Tools that exhibit clear advantages over state-of-the-art technologies in the hands of customers for their molecular workflows in the bioscience industry and academia.

Each of our products should meet several or all of the following criteria:

• Superior quality through modern DNA extraction technology
  
• Significantly fewer steps compared to conventional kit technology
  
• Flexibility in throughput – either spin or 96-well formats
  
• Drastically reduced time required compared to conventional DNA extraction kit technology
  
• Higher yield and recovery than conventional kit technology
  
• No hazardous materials & minimized plastic waste
  
• Fair price
  
• Our product portfolio includes the following product classes: EchoLUTION DNA extraction kits
  
• EchoCLEAN nucleic acid cleanup kits
  
• EchoSAFE buffers and reagents

Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational and life science research. The Quantabio team leverages decades of experience in developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on

• critical cloning,
• PCR,
• qPCR
• Next-Generation Sequencing (NGS)

based applications. Based in Beverly, Mass., USA

• Quanta BioSciences Achieves Milestone with the FDA Clearance of the CDC Influenza IVD kit which utilizes the Quanta 1-Step RT-qPCR technology. July 8, 2013​
  
• CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel (rRT-PCR Enzyme Mastermix Options, Page 6, 3/20/2020) - For Emergency Use Only

Catch Genes from Liquid Biopsy is what we are doing now. Founded in 2016, CatchGene Co., Ltd. groups experts from different fields, including molecular biology, electrical engineering, software engineering and mechanics.

Developing a better solution for purifying rare cfDNA or cfRNA from Liquid Biopsy. Molecular diagnostic is a rapid developing field. With more and more biomarker, nowadays people are able to predict, diagnostic or tracing many diseases.

Many people are focusing on how to increase the sensitivity of detection reagents or devices. But actually, the most important step is to catch DNA/RNA first.

CatchGene is focusing on get higher quality of cfDNA, cfRNA or miRNA from Liquid Biopsy and DNA/RNA Solid Biopsy because we know that DNA/RNA purification is the first step of achieving “Precision Medicine”. ​

Have a vision to overcome the bottle neck of Precision Medicine, we developed the iCATCHER system which able to purify cfDNA, miRNA from up to 4 ml Liquid Biopsy and extract high integrity DNA/RNA from FFPE tissue sample.

Circulating cell-free DNA (cfDNA) is proven as a great target to apply many different molecular diagnosis. Such as Non-Invasive Prenatal testing (NIPT) and Liquid Biopsy for cancer diagnosis. However, it's very rare and unstable. Therefore, how to purify higher purity and higher concentration cfDNA becomes an important issue! CatchGene are glad to provide you both manual and automated solutions which able to start from large sample volume (up to 4 ml) and elute in small eluate volume (30 ul).

Solutions for Cancer prediction, Cancer diagnostic and Cancer tracing.